Objectives: To identify initial predictive factors of renal involvement in children and adolescents with Henoch-Schönlein purpura.
Introduction
Henoch-Schönlein purpura (HSP), also known as anaphylactic purpura, nonthrombocytopenic purpura, rheumatic purpura or allergic purpura, is the most common type of vasculitis in the pediatric age group. [1] [2] [3] It is characterized by cutaneous, articular, gastrointestinal and renal involvement, while orchitis, vasculitis of the central nervous system (CNS) and pulmonary hemorrhage are rare findings. 2 The most characteristic clinical manifestation, and one which is found in all patients, is non-thrombocytopenic palpable purpura, symmetrically located and with a preference for the lower limbs and buttocks. [1] [2] [3] Kidney damage is the principal prognostic determinant in HSP, affecting between 10 and 50% of patients. [4] [5] [6] [7] The most common renal alterations are transitory hematuria and proteinuria, commonly with duration of less than 1 month. 1 Of those children who do continue to suffer from these urinary sediment alterations beyond the first month of the disease, around 30% exhibit complete recovery by the third month, rarely progressing with persistent hematuria and/or proteinuria or nephritic or nephrotic syndromes. 1,2 While prognosis is habitually favorable, patients with nephritis may progress to renal insufficiency. 8 There is a scarcity of studies of pediatric HSP patients employing multivariate analysis models that have evaluated the initial prognostic factors associated with renal involvement, [4] [5] [6] [7] and those that do exist generally investigate oriental populations. 4, 5, 7 Furthermore, these studies do not describe other initial alterations of this disease, such as orchitis, CNS vasculitis and pulmonary hemorrhage.
This being so, the objectives of this study were to evaluate renal involvement in patients with HSP and to identify initial factors, assessed during the first 3 months, that are predictive of nephritis, based on demographic data, clinical characteristics, laboratory test results and the treatment given to these patients.
Methods
The medical records of all 189 children and adolescents who were seen during a 21-year period (January, 1983 According to other studies in the medical literature, 4, 5, 10 HSP renal involvement or nephritis can be defined as the Abdominal pain was defined as mild (pain improves with paracetamol) or severe (abdominal angina, with diffuse abdominal pain that make eating impossible 7 and/or gastrointestinal bleeding 4, 9 ). Patients with severe abdominal pain either did not tolerate or did not respond to paracetamol.
Abdominal or testicular with Doppler ultrasound was employed to confirm diagnoses of intussusception or orchitis, respectively. This is important for ruling out orchitis secondary to vasculitis of the spermatic cord, which is rarely observed in HSP. 
Results
A total of 189 patients with HSP were treated during the 21-year period, and of these 142 patients were included in the study as their medical records provided complete data.
The principal clinical characteristics, laboratory tests and treatment of these patients with HSP are listed in Table 2 .
Forty-six percent of these 142 patients were male, 100% had palpable purpura, 28% persistent palpable purpura during the first month of the disease, 69% had arthritis, 62%
abdominal pain, 49% nephritis, 32% severe abdominal pain, 10% gastrointestinal bleeding, 9% orchitis (painful, acute scrotal edema associated with palpable purpuric lesions), and one patient (0.7%) suffered a cerebral vascular accident due to vasculitis of the CNS. None of the patients suffered pulmonary hemorrhage. Elevated serum IgA levels occurred in 43% (Table 2) . intestinal bleeding were given intravenous gammaglobulin.
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All 70 patients with nephritis had isolated hematuria or proteinuria (31 and 7%, respectively) or both (11%), two had nephrotic syndrome (1%) and two had renal insufficiency (1%) ( Table 4) .
Discussion
Kidney damage is the principal determinant of prognosis in HSP and occurs in between 10 and 50% of cases, predominantly among preschool children and schoolchildren with mean age of disease onset of 6 years, [1] [2] [3] [4] [5] [6] [7] in common with our study. The majority of these children develop nephritis during the first 3 weeks of the disease, 2 and it is uncommon for an initial renal injury to appear after other clinical manifestations have disappeared, as can be observed in 98% of our patients.
The remaining manifestations of HSP identified in the present study were similar to those found in the medical literature: palpable purpura (100%), persistent palpable purpura during the first month of the disease (22 to 62%), arthritis (50 to 74%), abdominal pain (55 to 72%), severe abdominal pain (15 to 60%), gastrointestinal bleeding (8.8 to 24%) and orchitis (2 to 32%). [1] [2] [3] [4] [5] [6] [7] In contrast, CNS involvement with cerebral vasculitis has rarely been described, 11 as was observed in just one of our patients. Henoch-Schönlein purpura nephritis -de Almeida JL et al.
One feature of this study population is that all patients with HSP seen at our Hospital, even those presenting with mild forms of the disease, were invariably treated by the Rheumatology and/or Pediatric Nephrology departments.
These patients were seen at the various clinics and the emergency room concomitantly by general pediatricians and specialists (rheumatologists and/or pediatric nephrologists).
Just four studies have assessed initial risk factors for nephritis of HSP using univariate and multivariate analysis models, and three of these were undertaken in oriental countries (Japan and Korea). In these studies nephritis occurred in between 21 and 49% of cases, [4] [5] [6] [7] which is comparable with our study.
Kaku et al. 4 found evidence that abdominal pains of severe intensity, persistent purpura, age over 7 years and reduced serum coagulation factor XIII levels were initial risk factors associated with HSP nephritis. Sano et al. Other randomized and placebocontrolled trials have also found that the use of prednisone at the start of HSP does not avert kidney damage. 14, 15 In our patients sample it was demonstrated that use of corticosteroids was associated with greater renal involvement, since these patients exhibited a greater frequency of severe gastrointestinal involvement and required these medications. These were habitually introduced during the first month of the disease and were predominantly indicated to control significant gastrointestinal manifestations, such as intermittent and severe abdominal pain in colic, and bleeding and intussusception. was not associated with the occurrence of HSP, but did increase genetic susceptibility to nephritis. Additionally, a study conducted by Ozkaya et al. 22 demonstrated that a polymorphism of the renin-angiotensin system gene was associated with a 3.5 times greater risk of nephritis.
Further studies are needed to identify the genetic markers for HSP, in order to predict which patients will develop severe nephritis and would benefit from immunosuppressive treatment with a reduced frequency of adverse events (pharmacogenetics). This being so, those patients with HSP who exhibit gastrointestinal symptoms during the first 3 months should be rigorously monitored, due to the increased risk of renal involvement.
